Special considerations for specific medications While the general principles apply across all GLP-1 receptor agonists, each medication has unique characteristics that affect injection site reaction patterns
Often dose-dependent and may lessen over time
For most infusions, yes we run a baseline metabolic, nutrient, and iron panel so we're treating actual deficiencies, not guessing
A single 5ml vial at 20mg/ml can last months at lower doses, which affects storage timeline significantly
In addition, the basal ganglia targeting efficiency and bloodbrain barrier penetration of ferroptosis inhibitors (such as Fer-1) have not been evaluated, and long-term safety data in HD patients are lacking, including whether treatment disturbs iron metabolism in unaffected brain regions and causes cognitive side effects